A University of Edinburgh startup developing rapid cell analysis for the biopharmaceutical industry has raised £4 million to scale up market-testing of its technology platform.
Innovative technology that creates ultra-thin layers of human cells in tube-like structures could spur development of lifelike blood vessels and intestines in the lab.
University of Edinburgh spinout eoSurgical has announced it has been acquired by Limbs & Things – a UK-based company that manufactures medical task trainers and simulators.
A new drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by biopharmaceutical company Nuvectis Pharma, Inc., has received US Food and Drug Administration (FDA) clearance to proceed to clinical trials.
An algorithm developed using artificial intelligence could soon be used by doctors to diagnose heart attacks with better speed and accuracy than ever before, according to new research from the University of Edinburgh, funded by charity the British Heart Foundation and the UK’s National Institute for Health and Care Research, and published today in Nature Medicine.
Student startup secures £2.2 million in funding to develop its soft robotic glove which aims to restore upper limb mobility in patients following a stroke.
A
team of scientists has developed smart electronic skin that could pave the way
for soft, flexible robotic devices to assist with surgical procedures or aid
people’s mobility.
What’s your next challenge? Spin in, spin out or start up?
